Biomedical Engineering Reference
In-Depth Information
31. Harel S, Janoff A, Yu SY, Hurewitz A, Bergofsky EH. Desmosine radioim-
munoassay for measuring elastin degradation in vivo. Am Rev Respir Dis
1980; l22:769-773.
32. Stone PJ, Gottlieb DJ, O'Connor GT, Ciccolella DE, Breuer R, Bryan-Rhadfi
J, et al. Elastin and collagen degradation products in urine of smokers with
and without chronic obstructive pulmonary disease. Am J Respir Crit Care
Med 1995; 151:952-959.
33. Akers S, Kucich U, Swartz M, Rosen G, Glass M, Rosenbloom J, et al.
Specificity and sensitivity of the assay for elastin-derived peptides in chronic
obstructive pulmonary disease. Am Rev Respir Dis 1992; 145:1077-1081.
34. Dillon TJ, Walsh RL, Scicchitano R, Eckert B, Cleary EG, McLennan G.
Plasma elastin-derived peptide levels in normal adults, children, and emphyse-
matous subjects. Physiologic and computed tomographic scan correlates. Am
Rev Respir Dis 1992; 146:1143-1148.
35. Kucich U, Christner P, Lippmann M, Kimbel P, Williams G, Rosenbloom J,
et al. Utilization of a peroxidase antiperoxidase complex in an enzyme-linked
immunosorbent assay of elastin-derived peptides in human plasma. Am Rev
Respir Dis 1985; 131:709-713.
36. Schriver EE, Davidson JM, Sutcliffe MC, Swindell BB, Bernard GR. Compar-
ison of elastin peptide concentrations in body fluids from healthy volunteers,
smokers, and patients with chronic obstructive pulmonary disease. Am Rev
Respir Dis 1992; 145:762-766.
37. Betsuyaku T, Nishimura M, Yoshioka A, Takeyabu K, Miyamoto K,
Kawakami Y. Elastin-derived peptides and neutrophil elastase in bronchoal-
veolar lavage fluid. Am J Respir Crit Care Med 1996; 154:720-724.
38. Davies SF, Offord KP, Brown MG, Campe H, Niewoehner D. Urine desmo-
sine is unrelated to cigarette smoking or to spirometric function. Am Rev
Respir Dis 1983; 128:473-475.
39. Pelham F, Wewers M, Crystal R, Buist AS, Janoff A. Urinary excretion of
desmosine (elastin cross-links) in subjects with PiZZ alpha-1-antitrypsin defi-
ciency, a phenotype associated with hereditary predisposition to pulmonary
emphysema. Am Rev Respir Dis 1985; 132:821-823.
40. Viglio S, Iadarola P, Lupi A, Trisolini R, Tinelli C, Balbi B, et al. MEKC of
desmosine and isodesmosine in urine of chronic destructive lung disease
patients. Eur Respir J 2000; 15:1039-1045.
41. Gottlieb DJ, Stone PJ, Sparrow D, Gale ME, Weiss ST, Snider GL, et al.
Urinary desmosine excretion in smokers with and without rapid decline of
lung function: the Normative Aging Study. Am J Respir Crit Care Med
1996; 154:1290-1295.
42. Rose NR. The role of infection in the pathogenesis of autoimmune disease.
Seminars in Immunology. 1998; 10:5-13.
43. Rao T, Richardson B. Environmentally induced autoimmune diseases: poten-
tial mechanisms. Environ Health Perspect 1999; 107(suppl 5):737-742.
44. Rose N, Afanasyeva M. Autoimmunity: busting the atherosclerotic plaque.
Nat Med 2003; 9:641-642.
